Literature DB >> 25415393

Short-Term effects of neuromuscular electrical stimulation on muscle architecture of the tibialis anterior and gastrocnemius in children with cerebral palsy: preliminary results of a prospective controlled study.

İlkay Karabay1, Gökhan Tuna Öztürk, Fevziye Ünsal Malas, Murat Kara, Tülay Tiftik, Murat Ersöz, Levent Özçakar.   

Abstract

OBJECTIVE: The aim of this study was to explore the short-term effects of neuromuscular electrical stimulation application on tibialis anterior (stimulated muscle) and gastrocnemius (antagonist) muscles' size and architecture in children with cerebral palsy by using ultrasound.
DESIGN: This prospective, controlled study included 28 children diagnosed with spastic diplegic cerebral palsy. Participants were treated either with neuromuscular electrical stimulation application and conventional physiotherapy (group A) or with conventional physiotherapy alone (group B). Outcome was evaluated by clinical (gross motor function, selective motor control, range of motion, spasticity) and ultrasonographic (cross-sectional area, pennation angle, fascicle length of tibialis anterior and gastrocnemius muscles) measurements before and after treatment in both groups.
RESULTS: Cross-sectional area values of tibialis anterior (238.7 ± 61.5 vs. 282.0 ± 67.1 mm) and gastrocnemius (207.9 ± 48.0 vs. 229.5 ± 52.4 mm) (P < 0.001 and P = 0.008, respectively) muscles were increased after treatment in group A. Cross-sectional area values of tibialis anterior muscle were decreased (257.3 ± 64.7 vs. 239.7 ± 60.0 mm) after treatment in group B (P < 0.001), and the rest of the measurements were found not to have changed significantly in either group.
CONCLUSIONS: These results have shown that cross-sectional area of both the agonist and antagonist muscles increased after 20 sessions of neuromuscular electrical stimulation treatment. Future studies with larger samples and longer follow-up are definitely awaited for better evaluation of neuromuscular electrical stimulation application on muscle architecture and its possible correlates in clinical/functional outcome.

Entities:  

Mesh:

Year:  2015        PMID: 25415393     DOI: 10.1097/PHM.0000000000000238

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  5 in total

1.  Neuromuscular structure of the tibialis anterior muscle for functional electrical stimulation.

Authors:  Kyu-Ho Yi; Liyao Cong; Jung-Hee Bae; Eun-Sook Park; Dong-Wook Rha; Hee-Jin Kim
Journal:  Surg Radiol Anat       Date:  2016-05-20       Impact factor: 1.246

2.  Does ultrasound imaging of the spastic muscle have an additive effect on clinical examination tools in patients with cerebral palsy?: A pilot study.

Authors:  Kardelen Gencer Atalay; Evrim Karadag Saygi; Firat Akbas; Ozge Kenis Coskun; Ahmet Hamdi Akgulle; Ilker Yagci
Journal:  North Clin Istanb       Date:  2022-03-11

3.  A Systematic Review of Training Methods That May Improve Selective Voluntary Motor Control in Children With Spastic Cerebral Palsy.

Authors:  Annina Fahr; Jeffrey W Keller; Hubertus J A van Hedel
Journal:  Front Neurol       Date:  2020-12-04       Impact factor: 4.003

Review 4.  Neuromuscular electrical stimulation to augment lower limb exercise and mobility in individuals with spastic cerebral palsy: A scoping review.

Authors:  Kelly R Greve; Christopher F Joseph; Blake E Berry; Kornel Schadl; Jessica Rose
Journal:  Front Physiol       Date:  2022-08-30       Impact factor: 4.755

5.  COpenhagen Neuroplastic TRaining Against Contractures in Toddlers (CONTRACT): protocol of an open-label randomised clinical trial with blinded assessment for prevention of contractures in infants with high risk of cerebral palsy.

Authors:  Maria Willerslev-Olsen; Jakob Lorentzen; Katrine Røhder; Anina Ritterband-Rosenbaum; Mikkel Justiniano; Andrea Guzzetta; Ane Vibeke Lando; Anne-Mette Bæk Jensen; Gorm Greisen; Sofie Ejlersen; Line Zacho Pedersen; Britta Andersen; Patricia Lipthay Behrend; Jens Bo Nielsen
Journal:  BMJ Open       Date:  2021-07-06       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.